Who owns Celldex Therapeutics?

Key details on Celldex Therapeutics (Ticker: CLDX)

Who owns Celldex Therapeutics?

Is CLDX a good stock to own? Find out who bought Celldex Therapeutics, who sold Celldex Therapeutics (CLDX) stock, and who holds a large position in Celldex Therapeutics.

Fund Name Number of Shares Share Valuation As Of
FMR 14.77M $372.55M June 30, 2015
OppenheimerFunds 8.79M $221.81M June 30, 2015
Franklin Resources 8.64M $217.88M June 30, 2015
Vanguard 6.36M $160.37M June 30, 2015
First Trust Advisors 4.34M $109.51M June 30, 2015
BlackRock Fund Advisors 3.64M $91.80M June 30, 2015
Jennison Associates 3.03M $39.24M Sept. 30, 2014
LORD, ABBETT & CO 2.67M $48.72M Dec. 31, 2014
STATE STREET CORPORATION 2.59M $65.41M June 30, 2015
Columbia Wanger Asset Management 2.59M $65.36M June 30, 2015
HealthCor Management 2.50M $8.88M June 30, 2011
Frontier Capital Management 2.50M $62.94M June 30, 2015
SUSQUEHANNA INTERNATIONAL 2.49M $32.31M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 2.32M $58.42M June 30, 2015
Sectoral Asset Management 2.23M $53.93M Dec. 31, 2013
Millennium Management 2.07M $57.70M March 31, 2015
OrbiMed Advisors 2.06M $37.64M Dec. 31, 2014
TimesSquare Capital Management 1.87M $47.26M June 30, 2015
BlackRock Advisors 1.83M $28.55M June 30, 2013
S.A.C. Capital Advisors 1.82M $32.14M March 31, 2014
First Eagle Investment Management 1.66M $8.62M June 30, 2012
Columbus Circle Investors 1.63M $29.71M Dec. 31, 2014
Wellington Management Company 1.62M $25.26M June 30, 2013
HealthCor Management 1.45M $22.63M June 30, 2013

Who sold Celldex Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Ridgeback Capital Investments Dec. 31, 2012 3.80M $25.53M
TSP Capital Management Sept. 30, 2011 1.47M $3.35M